Also, I'd add that ADAMS is a carer-derived assessment.
I can only imagine that there is a degree of enthusiasm and hope from the Carers (possibly with an overflow impact on the patient??) in the performance of these trials, particularly with positive Ph1 results publicly available.
To see no benefit, if you were on the Placebo arm, would be kind of demoralising and even more so if you know someone on the NTI 164 arm that was benefitting.
- Forums
- ASX - By Stock
- NTI
- Ann: Phase II/III autism trial shows further benefits
Ann: Phase II/III autism trial shows further benefits, page-13
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
7.1¢ |
Change
-0.005(6.58%) |
Mkt cap ! $72.23M |
Open | High | Low | Value | Volume |
7.6¢ | 7.8¢ | 6.9¢ | $135.0K | 1.833M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 27000 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.1¢ | 33439 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 27000 | 0.070 |
2 | 46286 | 0.069 |
2 | 41617 | 0.068 |
1 | 25000 | 0.067 |
4 | 258292 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.071 | 33439 | 1 |
0.073 | 172720 | 1 |
0.075 | 37501 | 3 |
0.076 | 66000 | 1 |
0.077 | 42000 | 1 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online